Skip to main content

Find Clinical Trials

Home
Conditions
Refractory T Lymphoblastic Leukemia/Lymphoma

Clinical trial condition

Refractory T Lymphoblastic Leukemia/Lymphoma

Explore clinical trials studying Refractory T Lymphoblastic Leukemia/Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Refractory T Lymphoblastic Leukemia/Lymphoma trial results

Completed

Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma

NCT04689659

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
Locations: Beijing Boren Hospital Beijing, Beijing Municipality, China

View Trial Details